GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MRT Inc (TSE:6034) » Definitions » Intrinsic Value: Projected FCF

MRT (TSE:6034) Intrinsic Value: Projected FCF : 円2,336.79 (As of May. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is MRT Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-27), MRT's Intrinsic Value: Projected FCF is 円2,336.79. The stock price of MRT is 円741.00. Therefore, MRT's Price-to-Intrinsic-Value-Projected-FCF of today is 0.3.

The historical rank and industry rank for MRT's Intrinsic Value: Projected FCF or its related term are showing as below:

TSE:6034' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.31   Med: 0.93   Max: 23.48
Current: 0.32

During the past 9 years, the highest Price-to-Intrinsic-Value-Projected-FCF of MRT was 23.48. The lowest was 0.31. And the median was 0.93.

TSE:6034's Price-to-Projected-FCF is ranked better than
93.27% of 312 companies
in the Healthcare Providers & Services industry
Industry Median: 1.29 vs TSE:6034: 0.32

MRT Intrinsic Value: Projected FCF Historical Data

The historical data trend for MRT's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MRT Intrinsic Value: Projected FCF Chart

MRT Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only - - 429.57 358.00 2,555.99

MRT Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,397.87 2,659.74 2,473.12 2,477.55 2,336.79

Competitive Comparison of MRT's Intrinsic Value: Projected FCF

For the Medical Care Facilities subindustry, MRT's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MRT's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MRT's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where MRT's Price-to-Projected-FCF falls into.



MRT Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get MRT's Free Cash Flow(6 year avg) = 円613.32.

MRT's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar24)*0.8)/Shares Outstanding (Diluted Average)
=(14.862653310476*613.32016+4510.331*0.8)/5.445
=2,336.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MRT  (TSE:6034) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

MRT's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=741.00/2336.7914979625
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MRT Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of MRT's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


MRT (TSE:6034) Business Description

Traded in Other Exchanges
N/A
Address
1-18-2 Kanan, 3rd Floor, Frame Kananzaka, Shibuya-ku, Tokyo, JPN, 150-0041
MRT Inc engages in the business of medical personnel placement services through Internet. It provides part-time and full-time physician referral services through physician referral site MedRT.com; as well as part-time job referral; job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.

MRT (TSE:6034) Headlines

No Headlines